Nivolumab Induces Durable Remission in Relapsed/Refractory ALK-Negative ALCL After Allogeneic Blood Stem Cell Transplantation-A Case Report and Literature Review. This evidence concerns the gene ALK and anaplastic large cell lymphoma.